Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Stocks end with modest gain, but down on week overall

Fri, 26th Sep 2014 16:48

UK stocks ended the final session of the week with a modest rise, although on the week the index was significantly lower.The FTSE 100 closed 9.68 points higher at 6,649.39.Markets are concerned about mounting geopolitical tensions, with the government due to take a vote on whether to participate in a war against the "Islamic State" on Friday evening.David Cameron and Ed Miliband took to the stands in the House of Commons on Friday morning in an attempt to persuade parliament to support airstrikes against Islamic State (IS) militants in Iraq.Cameron urged members to support military action in the region, underlining Britain's clear basis for action in international law, strengthened by a direct request for British intervention made by the Iraqi government.The Prime Minister also highlighted the international coalition's need for Britain's unique military and intelligence capabilities in order to fight the Islamist militant group."Is there a threat to the British people? The answer is yes," Cameron told parliament, saying he thought action would need to last "years" to be effective.Members are expected to vote in favour of entering the conflict.Soaring house prices could drive workers away from LondonLondon could be waving goodbye to a number of workers in the future, as the struggle to meet living costs in the British capital continues to rise.London's housing shortage could put the city's future at risk unless swift actions are taken to address one of the capital's chronic problems, research conducted by YouGov shows.Japanese CPI disappointsLooking abroad, Japanese consumer price inflation came in weaker than expected for August. The headline inflation rate slowed to a 3.3% year-on-year pace from 3.4%, with the ex-fresh food measure down to 3.1% from 3.3% (consensus: 3.2%)."Softer Japanese CPI data reinforced fears of more BoJ easing and hurt the JPY," analysts at UnicreditResearch said.Over in the States, gross domestic product (GDP) was revised higher in the second quarter, supported by better retail sales and foreign trade numbers.The US economy grew at a 4.6% annual rate in the three months to end of June, as predicted by analysts.Easyjet shares take off thanks to comments from JefferiesShares in Easyjet flew higher after Jefferies said the airline was situated to benefit from the recent problems with Air France-KLM, which has been forced to cancel numerous flights due to pilot strike action. The broker also predicted the group would have a positive finish to the year.Astrazeneca shares also squeezed higher after the company received positive feedback for Moventig, its new treatment for opioid-induced constipation.British Land shares were lifted by Societe Generale after it lifted its rating from 'hold' to 'buy'.Meanwhile, Sports Direct shares slumped into the red one day after its boss, Mike Ashley, yesterday surprised the market with the news it has completed a "put" option with Goldman Sachs in a complicated move that it said "reflects Sports Direct's growing relationship with Tesco and belief in Tesco's long-term future". The option relates to 23m Tesco shares.Tesco, together with its sector peers Sainsbury and Morrison, all continued to decline amid the growing price war amongst supermarkets.Slower-than-expected growth in its solutions division and challenging market conditions in its currency division have forced security documents designer and producer De La Rue to issue a profit warning, sending shares sharply lower.The FTSE 250 company said it expects operating profit and underlying profit before tax for the year to be £20m lower than originally estimated.Market MoverstechMARK 2,810.43 +0.37%FTSE 100 6,649.39 +0.15%FTSE 250 15,383.69 -0.27%FTSE 100 - RiserseasyJet (EZJ) 1,393.00p +3.19%St James's Place (STJ) 739.00p +2.78%British Land Co (BLND) 706.00p +2.10%Fresnillo (FRES) 761.50p +1.80%Shire Plc (SHP) 5,330.00p +1.72%ARM Holdings (ARM) 919.00p +1.66%Admiral Group (ADM) 1,253.00p +1.62%International Consolidated Airlines Group SA (CDI) (IAG) 370.70p +1.51%Hammerson (HMSO) 571.50p +1.51%Intu Properties (INTU) 330.50p +1.47%FTSE 100 - FallersSainsbury (J) (SBRY) 250.10p -3.06%Sports Direct International (SPD) 620.50p -2.67%Morrison (Wm) Supermarkets (MRW) 171.00p -1.78%Imperial Tobacco Group (IMT) 2,647.00p -1.78%IMI (IMI) 1,244.00p -1.66%Petrofac Ltd. (PFC) 1,010.00p -1.08%CRH (CRH) 1,389.00p -1.00%BG Group (BG.) 1,127.50p -0.97%TUI Travel (TT.) 387.50p -0.95%3i Group (III) 384.60p -0.88%FTSE 250 - RisersSupergroup (SGP) 1,136.00p +4.22%Fidessa Group (FDSA) 2,303.00p +3.00%Betfair Group (BET) 1,172.00p +2.99%Pets at Home Group (PETS) 176.00p +2.92%Evraz (EVR) 127.10p +2.92%Zoopla Property Group (WI) (ZPLA) 234.90p +2.76%SEGRO (SGRO) 365.40p +2.50%Millennium & Copthorne Hotels (MLC) 556.00p +2.39%Balfour Beatty (BBY) 224.90p +2.13%Capital & Counties Properties (CAPC) 332.40p +2.03%FTSE 250 - FallersDe La Rue (DLAR) 504.00p -33.60%Greencore Group (GNC) 240.80p -4.82%Ocado Group (OCDO) 267.40p -3.67%Daejan Holdings (DJAN) 4,878.00p -3.31%Hochschild Mining (HOC) 139.70p -2.92%Vesuvius (VSVS) 452.50p -2.88%Synthomer (SYNT) 215.00p -2.80%Playtech (PTEC) 716.00p -2.78%African Barrick Gold (ABG) 207.50p -2.72%Soco International (SIA) 372.40p -2.69%
More News
4 Sep 2023 12:13

LONDON MARKET MIDDAY: Hopes of rate peak, China turnaround lift stocks

(Alliance News) - Stock prices in London were higher at midday on Monday, with market mood buoyed by news of stimulus measures in China and increasing optimism for the future of interest rates across the Atlantic.

Read more
4 Sep 2023 08:25

IN BRIEF: Astra drug gets China okay for chronic lymphocytic leukaemia

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Astra's Calquence is approved in China for treatment of chronic lymphocytic leukaemia or small lymphocytic lymphoma in adult patients who have received at least one prior therapy. The National Medical Products Administration approves Calquence, whose generic name is acalabrutinib, based on two different trials, including one in China. Astra notes that CLL is the most prevalent type of adult leukaemia around the world and represents about 6.4% of B-cell non-Hodgkin lymphoma patients in China. Calquence already is approved for treatment of CLL and SLL in the US and Japan and is approved for CLL in the EU.

Read more
4 Sep 2023 07:36

LONDON BRIEFING: CMC names new CFO; takeover offer for Ergomed

(Alliance News) - Stocks in London are expected to open on a positive note on Monday, amid an improvement in global risk sentiment.

Read more
29 Aug 2023 20:24

Blood thinners, diabetes meds among first 10 drugs for US price negotiations

Aug 29(Reuters) - The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.

Read more
29 Aug 2023 12:33

US government names first 10 drugs for Medicare price negotiation

Aug 29 (Reuters) - The Biden administration on Tuesday released its list of 10 prescription medicines including blood thinner Eliquis from Bristol Myers Squibb and Pfizer that will be subject to the first-ever price negotiations by the Medicare health program.

Read more
29 Aug 2023 11:00

US to name first 10 drugs for Medicare price negotiation

Aug 29(Reuters) - The Biden administration on Tuesday is expected to release its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people.

Read more
25 Aug 2023 11:59

Novo says Wegovy drug helps obese people with heart failure in trial

Aug 25 (Reuters) - Novo Nordisk said its hugely popular drug Wegovy was shown to substantially ease heart failure in obese people, as the Danish drugmaker seeks to further build its case for the medicine's health benefits beyond weight loss.

Read more
24 Aug 2023 16:24

UPDATE: AstraZeneca, Merck & Co say Lynparza approved in Japan

(Alliance News) - AstraZeneca PLC and Merck & Co Inc on Thursday jointly said its Lynparza treatments have been approved in Japan.

Read more
24 Aug 2023 08:25

AstraZeneca says Soliris and Lynparza approved in Japan

(Alliance News) - AstraZeneca PLC on Thursday said both its Soliris and Lynparza treatments have been approved in Japan.

Read more
23 Aug 2023 16:15

AstraZeneca facing two London lawsuits over COVID-19 vaccines

LONDON, Aug 23 (Reuters) - AstraZeneca is facing two London lawsuits, including one from the husband of a woman who died after receiving the Anglo-Swedish drugmaker's COVID-19 vaccine, in the first of potentially dozens of cases brought in England.

Read more
23 Aug 2023 12:10

LONDON MARKET MIDDAY: Stocks rise but pound slumps on sub-par UK data

(Alliance News) - Stocks in Europe were on the up heading into Wednesday afternoon, with equity markets in a confident mood on the eve of the Jackson Hole central banking event, shaking off tepid economic data which hurt the pound and euro.

Read more
23 Aug 2023 07:42

Daiichi Sankyo and AstraZeneca's Enhertu wins new approval in Japan

(Alliance News) - AstraZeneca PLC's partner Daiichi Sankyo Co Ltd on Wednesday announced that their cancer drug Enhertu has received another approval in Japan.

Read more
22 Aug 2023 06:06

Pay for FTSE 100 bosses jumps 16% as wider wages behind inflation

(Alliance News) - The bosses of Britain's biggest companies saw their pay surge by 16% last year as most workers saw their pay packets outstripped by inflation, according to new research.

Read more
21 Aug 2023 22:37

US FDA approves Pfizer's maternal RSV vaccine to protect infants

Aug 21 (Reuters) - The U.S. Food and Drug Administration on Monday approved Pfizer's respiratory syncytial virus (RSV) vaccine for use in women during the middle of the third trimester of pregnancy to protect their babies.

Read more
21 Aug 2023 20:56

Britain's CEOs get 16% pay rise to 3.9 mln pounds even as workers struggle

LONDON, Aug 21 (Reuters) - The bosses of Britain's biggest companies saw their pay jump 16% in 2022, sending their average earnings to 118 times the median UK full-time worker's while employees struggled with soaring inflation, new research showed on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.